Login

Log In to SINEORA
Login with your social media account
or
Use your corporate e-mail address
New to SINEORA?
Find the best technology startups for your innovation or join our startup program. Create an account

register

Sign Up: Create your company account

By sign up you get the following benefits:

  • Select best local partner to continuously enrich our pipeline
  • Pre-screening relevant ones
  • Pre-screening the startups in our focused domain, namely AI, Industrial IoT, B2B software, Robotics and Blockchain
  • Startups Assessment Report (360-degree view with our originally developed methodology)
  • Deep understanding of corporates’ digital transformation challenges and constraints
  • Focusing on synergized scenario
  • Fine tune process empowered by our algorithm (per initiative)

Select the better description for your innovation company

If you already have an account,

corporate form

startup form

Startup Search Results / GenSight Biologics
GenSight Biologics

GenSight Biologics

Develops innovative therapies for mitochondrial and neurodegenerative diseases

36 employees
Launch date : 2013
Date Investor Amount
- IBionextAgoranov
N/A
Apr 2013 Index VenturesNovartis Venture FundAbingworth LLPVersant Ventures SERIES A
€32m
Jul 2015 Index VenturesNovartis Venture FundAbingworth LLPHealthCapFidelityJennison AssociatesVersant VenturesPerceptive Advisors SERIES B
$36m
Jul 2016 N/A IPO*
€45.3m
Jul 2017* N/A POST IPO EQUITY
€22.5m
Feb 2019 Sofinnova Partners GROWTH EQUITY
$9.1m
Dec 2019 Kreos CapitalSofinnova Partners3SBio POST IPO DEBT
$16.6m
Investor Amount
Abingworth LLP SERIES B, SERIES A
Novartis Venture Fund SERIES B, SERIES A
Index Ventures SERIES B, SERIES A
HealthCap SERIES B
Fidelity SERIES B
Jennison Associates SERIES B
Perceptive Advisors SERIES B
Versant Ventures SERIES B, SERIES A
Sofinnova Partners POST IPO DEBT, GROWTH EQUITY
3SBio POST IPO DEBT
Kreos Capital POST IPO DEBT
IBionext
Agoranov

RECENT NEWS

INTERACT WITH THIS STARTUP